Tuesday, September 04, 2007
Canadian Cystic Fibrosis Foundation
Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
Toronto, ON (September 4, 2007) – The
results of a clinical trial, published in late August
in the Journal of Pediatrics, indicates that, when
used as part of routine therapy, high-dose
ibuprofen is safe, and effective in slowing down
lung disease in children with cystic fibrosis (CF).
Headed by Dr. Larry Lands, Director of Pediatric
Respiratory Medicine at Montreal Children’s
Hospital of the McGill University Health Centre,
the multi-centre study monitored 142 children
aged six to 18 with mild lung disease over two
years.
Children given high-dose ibuprofen twice a day
showed a significant reduction in the rate of
decline in lung function, and had fewer and
shorter hospital stays.
“Slowing the rate of the decline of lung function
will result in enhanced longevity and quality of
life for patients with CF,” said Dr. Larry Lands.
“Many treatments for cystic fibrosis can be a
financial hardship for families,” said Cathleen
Morrison, Chief Executive Officer at the Canadian
Cystic Fibrosis Foundation. “News that ibuprofen –
a relatively inexpensive treatment compared to
other therapies for CF – is effective, is very
exciting.”
"We are delighted to share this great news. The
findings of this study show that through research
and innovation, a simple inexpensive treatment
can have a profound impact on the lives of
children affected by CF and their families," said
Dr. Peter Liu, Scientific Director of CIHR`s Institute
of Circulatory and Respiratory Health.
The study was funded by the Canadian Cystic
Fibrosis Foundation and the Canadian Institutes of
Health Research.
For more information, please contact:
Sagal Ali
Media Relations Officer
Canadian Cystic Fibrosis Foundation
416-485-9149 ext. 290
sali@cysticfibrosi
s.ca
www.cysticfibrosis.
ca
Isabelle Kling
Communications Coordinator (research)
MUHC Public Relations and
Communications
514)-934-1934 #36419
isabelle.kling@muhc.mcgill.ca
|